Genenta Science S.p.A. (GNTA)

Nasdaq Biotechnology Diagnostics SIC: 2836
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT03866109 A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT PHASE2 Active Not Recruiting 27

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis